⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 15, 2024

Supplementary Figure 5 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors

Sophie Archer Phillip M. Brailey Minjung Song Phillip D. Bartlett Ines Figueiredo Bora Gürel Christina Guo Verena Brucklacher-Waldert H. Lorraine Thompson Jude Akinwale Samantha E. Boyle Christine Rossant Neil R. Birkett Julia Pizzey Mark Maginn James Legg Richard Williams Colette M. Johnston Philip Bland‐Ward Johann S. de Bono Andrew J. Pierce

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Supplementary Figure 5: CB307 binding to cell-presented targets

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Archer et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2a2b6db64358766d10f https://doi.org/10.1158/1078-0432.25603495

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 5 from CB307: A Dual Targeting Costimulatory Humabody V<sub>H</sub> Therapeutic for Treating PSMA-Positive Tumors2024
2Supplementary Figure 4 from CB307: A Dual Targeting Costimulatory Humabody V<sub>H</sub> Therapeutic for Treating PSMA-Positive Tumors2024
3Supplementary Figure 4 from CB307: A Dual Targeting Costimulatory Humabody V<sub>H</sub> Therapeutic for Treating PSMA-Positive Tumors2024
4Supplementary Figure 1 from CB307: A Dual Targeting Costimulatory Humabody V<sub>H</sub> Therapeutic for Treating PSMA-Positive Tumors2024
5Supplementary Figure 1 from CB307: A Dual Targeting Costimulatory Humabody V<sub>H</sub> Therapeutic for Treating PSMA-Positive Tumors2024